IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
University of Alabama at Birmingham, Birmingham, Alabama National Jewish Health, Denver, Colorado Johns Hopkins University, Baltimore, Maryland The Minnesota Cystic Fibrosis Center, Minneapolis, Minnesota Nationwide Children's Hospital, Columbus, Ohio University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania Medical University of South Carolina, Charleston, South Carolina University of Texas Southwestern, Dallas, Texas University of Vermont Medical Center, Burlington, Vermont University of Washington Medical Center, Seattle, Washington Last updated October 2025